vs
Side-by-side financial comparison of BALCHEM CORP (BCPC) and Westrock Coffee Co (WEST). Click either name above to swap in a different company.
Westrock Coffee Co is the larger business by last-quarter revenue ($339.5M vs $263.6M, roughly 1.3× BALCHEM CORP). BALCHEM CORP runs the higher net margin — 14.9% vs -6.6%, a 21.5% gap on every dollar of revenue. On growth, Westrock Coffee Co posted the faster year-over-year revenue change (48.3% vs 9.8%). Over the past eight quarters, Westrock Coffee Co's revenue compounded faster (32.8% CAGR vs 4.9%).
Balchem Corp is a global specialty chemicals and nutritional ingredients provider that develops, manufactures and distributes application-specific products for human nutrition, animal health, pharmaceutical and industrial end markets, serving customers across North America, Europe and Asia Pacific.
Westrock Coffee Co is a global integrated coffee, tea and functional beverage solutions provider. It sources, roasts, manufactures and distributes coffee products, ready-to-drink beverages and custom formulations for retail, foodservice and commercial clients across North America and other key markets.
BCPC vs WEST — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $263.6M | $339.5M |
| Net Profit | $39.2M | $-22.6M |
| Gross Margin | 35.6% | 11.5% |
| Operating Margin | 19.8% | -2.6% |
| Net Margin | 14.9% | -6.6% |
| Revenue YoY | 9.8% | 48.3% |
| Net Profit YoY | 16.8% | 8.3% |
| EPS (diluted) | $1.21 | $-0.22 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $263.6M | $339.5M | ||
| Q3 25 | $267.6M | $354.8M | ||
| Q2 25 | $255.5M | $280.9M | ||
| Q1 25 | $250.5M | $213.8M | ||
| Q4 24 | $240.0M | $229.0M | ||
| Q3 24 | $239.9M | $220.9M | ||
| Q2 24 | $234.1M | $208.4M | ||
| Q1 24 | $239.7M | $192.5M |
| Q4 25 | $39.2M | $-22.6M | ||
| Q3 25 | $40.3M | $-19.1M | ||
| Q2 25 | $38.3M | $-21.6M | ||
| Q1 25 | $37.1M | $-27.2M | ||
| Q4 24 | $33.6M | $-24.6M | ||
| Q3 24 | $33.8M | $-14.3M | ||
| Q2 24 | $32.1M | $-17.8M | ||
| Q1 24 | $29.0M | $-23.7M |
| Q4 25 | 35.6% | 11.5% | ||
| Q3 25 | 35.7% | 11.7% | ||
| Q2 25 | 36.4% | 14.7% | ||
| Q1 25 | 35.2% | 13.6% | ||
| Q4 24 | 36.0% | 16.6% | ||
| Q3 24 | 35.6% | 16.8% | ||
| Q2 24 | 35.5% | 19.9% | ||
| Q1 24 | 34.0% | 19.4% |
| Q4 25 | 19.8% | -2.6% | ||
| Q3 25 | 20.4% | -2.4% | ||
| Q2 25 | 20.1% | -5.3% | ||
| Q1 25 | 20.4% | -6.1% | ||
| Q4 24 | 19.8% | -4.3% | ||
| Q3 24 | 20.0% | -5.8% | ||
| Q2 24 | 19.6% | -7.9% | ||
| Q1 24 | 17.4% | -5.3% |
| Q4 25 | 14.9% | -6.6% | ||
| Q3 25 | 15.1% | -5.4% | ||
| Q2 25 | 15.0% | -7.7% | ||
| Q1 25 | 14.8% | -12.7% | ||
| Q4 24 | 14.0% | -10.7% | ||
| Q3 24 | 14.1% | -6.5% | ||
| Q2 24 | 13.7% | -8.5% | ||
| Q1 24 | 12.1% | -12.3% |
| Q4 25 | $1.21 | $-0.22 | ||
| Q3 25 | $1.24 | $-0.20 | ||
| Q2 25 | $1.17 | $-0.23 | ||
| Q1 25 | $1.13 | $-0.29 | ||
| Q4 24 | $1.03 | $-0.26 | ||
| Q3 24 | $1.03 | $-0.16 | ||
| Q2 24 | $0.98 | $-0.20 | ||
| Q1 24 | $0.89 | $-0.27 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $74.6M | $49.9M |
| Total DebtLower is stronger | — | $444.1M |
| Stockholders' EquityBook value | $1.3B | $-1.9M |
| Total Assets | $1.7B | $1.2B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $74.6M | $49.9M | ||
| Q3 25 | $65.1M | $34.0M | ||
| Q2 25 | $65.4M | $44.0M | ||
| Q1 25 | $49.9M | $33.1M | ||
| Q4 24 | $49.5M | $26.2M | ||
| Q3 24 | $73.7M | $22.4M | ||
| Q2 24 | $63.7M | $24.3M | ||
| Q1 24 | $60.3M | $12.6M |
| Q4 25 | — | $444.1M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $393.1M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $1.3B | $-1.9M | ||
| Q3 25 | $1.3B | $11.4M | ||
| Q2 25 | $1.3B | $18.2M | ||
| Q1 25 | $1.2B | $71.4M | ||
| Q4 24 | $1.1B | $97.5M | ||
| Q3 24 | $1.2B | $110.3M | ||
| Q2 24 | $1.1B | $81.5M | ||
| Q1 24 | $1.1B | $91.7M |
| Q4 25 | $1.7B | $1.2B | ||
| Q3 25 | $1.7B | $1.2B | ||
| Q2 25 | $1.7B | $1.2B | ||
| Q1 25 | $1.6B | $1.1B | ||
| Q4 24 | $1.6B | $1.1B | ||
| Q3 24 | $1.6B | $1.1B | ||
| Q2 24 | $1.6B | $1.1B | ||
| Q1 24 | $1.6B | $983.3M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 4.03× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $67.3M | $36.7M |
| Free Cash FlowOCF − Capex | — | $27.8M |
| FCF MarginFCF / Revenue | — | 8.2% |
| Capex IntensityCapex / Revenue | — | 2.6% |
| Cash ConversionOCF / Net Profit | 1.72× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-107.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $67.3M | $36.7M | ||
| Q3 25 | $65.6M | $-26.6M | ||
| Q2 25 | $47.3M | $-7.0M | ||
| Q1 25 | $36.5M | $-22.1M | ||
| Q4 24 | $52.3M | $2.8M | ||
| Q3 24 | $51.3M | $-332.0K | ||
| Q2 24 | $45.0M | $-23.7M | ||
| Q1 24 | $33.4M | $8.0M |
| Q4 25 | — | $27.8M | ||
| Q3 25 | — | $-44.7M | ||
| Q2 25 | — | $-27.5M | ||
| Q1 25 | — | $-63.4M | ||
| Q4 24 | — | $-15.4M | ||
| Q3 24 | — | $-36.7M | ||
| Q2 24 | — | $-59.9M | ||
| Q1 24 | — | $-60.9M |
| Q4 25 | — | 8.2% | ||
| Q3 25 | — | -12.6% | ||
| Q2 25 | — | -9.8% | ||
| Q1 25 | — | -29.7% | ||
| Q4 24 | — | -6.7% | ||
| Q3 24 | — | -16.6% | ||
| Q2 24 | — | -28.7% | ||
| Q1 24 | — | -31.7% |
| Q4 25 | — | 2.6% | ||
| Q3 25 | — | 5.1% | ||
| Q2 25 | — | 7.3% | ||
| Q1 25 | — | 19.3% | ||
| Q4 24 | — | 7.9% | ||
| Q3 24 | — | 16.5% | ||
| Q2 24 | — | 17.4% | ||
| Q1 24 | — | 35.8% |
| Q4 25 | 1.72× | — | ||
| Q3 25 | 1.63× | — | ||
| Q2 25 | 1.23× | — | ||
| Q1 25 | 0.98× | — | ||
| Q4 24 | 1.56× | — | ||
| Q3 24 | 1.52× | — | ||
| Q2 24 | 1.40× | — | ||
| Q1 24 | 1.15× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BCPC
| Human Nutrition And Health | $166.1M | 63% |
| Animal Nutrition And Health | $61.2M | 23% |
| Specialty Products | $34.8M | 13% |
WEST
| Coffee And Tea | $202.6M | 60% |
| Flavors Extracts And Ingredients | $69.6M | 21% |
| Sustainable Sourcing And Traceability Segments | $66.9M | 20% |
